Recombinant erythropoietin and blood transfusion in selected preterm infants (Q35556474)

8 August 2017

title

Recombinant erythropoietin and blood transfusion in selected preterm infants (English)

1 reference

8 August 2017

0 references

1 reference

Meyer MP

1 reference

8 August 2017

Sharma E

series ordinal

1 reference

8 August 2017

Carsons M

series ordinal

1 reference

8 August 2017

publication date

1 January 2003

1 reference

Archives of Disease in Childhood. Fetal and Neonatal Edition

8 August 2017

published in

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

page(s)

F41-5

1 reference

Blood transfusions and human recombinant erythropoietin in premature newborn infants

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756013

Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756013

Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756013

Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756013

High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756013

The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756013

Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756013

Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1756013

Effect of protein intake on erythropoiesis during erythropoietin treatment of anemia of prematurity

26 September 2018

1 reference

12 December 2020

Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial

1 reference

12 December 2020

Comparison between two and five doses a week of recombinant human erythropoietin for anemia of prematurity: a randomized trial

1 reference

12 December 2020

Is the use of recombinant human erythropoietin in anaemia of prematurity cost-effective?

1 reference

12 December 2020

Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions

1 reference

12 December 2020

The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: A randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Identifiers

DOI

10.1136/FN.88.1.F41

1 reference

8 August 2017

1 reference

8 August 2017

1 reference